Published in Korean J Pediatr on February 28, 2011
Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities. Mol Psychiatry (2013) 1.12
Clinical and genetic features of Prader-Willi syndrome in China. Eur J Pediatr (2013) 0.78
Weight control and behavior rehabilitation in a patient suffering from Prader Willi syndrome. BMC Res Notes (2016) 0.75
The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science (2005) 4.54
Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc Natl Acad Sci U S A (2000) 4.54
Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet (2008) 4.10
Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet (2001) 3.92
Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints. Am J Hum Genet (1999) 2.71
Prader-Willi syndrome. Eur J Hum Genet (2008) 2.59
Gene structure, DNA methylation, and imprinted expression of the human SNRPN gene. Am J Hum Genet (1996) 2.41
The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics (2001) 2.37
Methylation-specific PCR simplifies imprinting analysis. Nat Genet (1997) 2.33
An imprinted, mammalian bicistronic transcript encodes two independent proteins. Proc Natl Acad Sci U S A (1999) 2.05
Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med (2005) 2.04
Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A (2008) 1.96
A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum Mol Genet (2009) 1.95
Prader-Willi syndrome and Angelman syndrome. Am J Med Genet C Semin Med Genet (2010) 1.95
Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet (2001) 1.94
Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab (2008) 1.87
A DNA methylation imprint, determined by the sex of the parent, distinguishes the Angelman and Prader-Willi syndromes. Genomics (1992) 1.82
Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics (2004) 1.81
Molecular characterization of two proximal deletion breakpoint regions in both Prader-Willi and Angelman syndrome patients. Am J Hum Genet (1995) 1.78
Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res (2004) 1.71
Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A (2004) 1.69
Autism spectrum disorders in Prader-Willi and Angelman syndromes: a systematic review. Psychiatr Genet (2005) 1.64
Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome. Hum Genet (2004) 1.60
Small nuclear ribonucleoprotein polypeptide N (SNRPN), an expressed gene in the Prader-Willi syndrome critical region. Nat Genet (1992) 1.57
Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf) (2006) 1.55
Critical periods of brain growth and cognitive function in children. Brain (2003) 1.53
Prader-Willi syndrome. J Med Genet (1997) 1.52
Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlations. Eur J Hum Genet (2007) 1.52
Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. Endocr Rev (2001) 1.46
Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol (2002) 1.42
Array-based comparative genomic hybridization analysis of recurrent chromosome 15q rearrangements. Am J Med Genet A (2005) 1.35
Genomic imprinting: potential function and mechanisms revealed by the Prader-Willi and Angelman syndromes. Mol Hum Reprod (1997) 1.30
Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet (2003) 1.29
Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol (2002) 1.27
Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab (2002) 1.22
Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment. J Intellect Disabil Res (1995) 1.20
Minimum prevalence, birth incidence and cause of death for Prader-Willi syndrome in Flanders. Eur J Hum Genet (2004) 1.16
Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab (2003) 1.15
Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am J Med Genet A (2008) 1.13
Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab (2010) 1.11
Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A (2007) 1.10
Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Clin Endocrinol (Oxf) (2007) 1.08
snoTARGET shows that human orphan snoRNA targets locate close to alternative splice junctions. Gene (2007) 1.07
Acute idiopathic gastric dilation with gastric necrosis in individuals with Prader-Willi syndrome. Am J Med Genet (1997) 1.05
Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J Clin Endocrinol Metab (2005) 1.04
Characteristics of abnormal food-intake patterns in children with Prader-Willi syndrome and study of effects of naloxone. Am J Clin Nutr (1987) 1.02
Profiles, correlates, and trajectories of intelligence in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry (1992) 0.97
A long-term population-based clinical and morbidity review of Prader-Willi syndrome in Western Australia. J Intellect Disabil Res (2006) 0.95
Insulin-like growth factor 1 (IGF-1) receptors in the human brain: quantitative autoradiographic localization. Brain Res (1989) 0.93
Early diagnosis and multidisciplinary care reduce the hospitalization time and duration of tube feeding and prevent early obesity in PWS infants. Horm Res (2007) 0.92
Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr (2003) 0.90
ADHD symptoms and insistence on sameness in Prader-Willi syndrome. J Intellect Disabil Res (2005) 0.90
Neonatal hypotonia: don't forget the Prader-Willi syndrome. Acta Paediatr (2003) 0.88
Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. J Pediatr (1999) 0.87
Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. J Pediatr (2004) 0.86
Reference values for height and weight in Prader-Willi syndrome based on 315 patients. Eur J Pediatr (1998) 0.85
Spontaneous growth in German children and adolescents with genetically confirmed Prader-Willi syndrome. Acta Paediatr (2000) 0.84
Prader-Willi syndrome: a review with special attention to the cognitive and behavioral profile. Birth Defects Orig Artic Ser (1992) 0.84
Phenotypic heterogeneity of growth and psychometric intelligence in Prader-Willi syndrome: variable expression of a contiguous gene syndrome or parent-child resemblance? Am J Med Genet (2000) 0.83
Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin. Horm Res (2006) 0.82
Polysomnographic findings in five adult patients with pituitary insufficiency before and after cessation of human growth hormone replacement therapy. Clin Endocrinol (Oxf) (2002) 0.82
Premature adrenarche, increased growth velocity and accelerated bone age in male patients with Prader-Labhart-Willi syndrome. Eur J Pediatr (2001) 0.78
Growth hormone treatment in a girl with Prader Willi syndrome. Indian J Pediatr (2003) 0.76
Growth hormone and respiratory compromise in Prader-Willi Syndrome. Arch Dis Child (2006) 0.76
Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome? Eur J Pediatr (2000) 0.76